Home - News

News

Custom formulations adapted to poorly water-soluble active ingredients

  • By Adjuvatis
  • on Mar 24, 2021
Anyone working on the development of active ingredients knows the difficulties encountered during this lengthy process, right from the R&D.
Read More

Versatile formulation of active ingredients, adapted to poorly water-soluble or rapidly metabolised drugs, allowing their solubilisation, protection and targeted delivery

  • By Adjuvatis
  • on Mar 02, 2021
Interested in Adjuvatis’ drug formulation technology but want to learn more? Meet us at the Forum de la Recherche en.
Read More

Improving antibiotic delivery in Staphylococcus aureus biofilms

  • By Adjuvatis
  • on Jan 13, 2021
Da Costa D, et al., Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
Read More

Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering

  • By Adjuvatis
  • on Jan 13, 2021
Bekhouche M, et al., Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering J. Mater. Chem. B, 2020.
Read More

Adjuvatis’ young talents

  • By Adjuvatis
  • on Jan 13, 2021
Congratulations to Dr David Da Costa for his PhD defense, in December 2020 !! Development of combinatorial therapy based on.
Read More

Adjuvatis’ young talents

  • By Adjuvatis
  • on Jan 13, 2021
Targeting Steatosis with Autophagy-Inducing Particles. A poster presented by Stavroula Zagkou, PhD Candidate from DRIVE-Autophagy ETN Dec 2020 – Drug.
Read More

2020: Adjuvatis remained by your side

  • By Adjuvatis
  • on Jan 13, 2021
2020 has been full of regular meetings, we look forward to seeing you in 2021!   Dec 2020 – BioFit.
Read More

Solubilization of an hydrophobic API for anti-cancer treatment

  • By Adjuvatis
  • on Juin 18, 2020
Poor water solubility is one of the most significant barrier limiting drug development. Indeed, more than 40% of compounds identified.
Read More
[ess_grid alias= »images-lyon »]